Old Web
English
Sign In
Acemap
>
authorDetail
>
Kayla Teopiz
Kayla Teopiz
Major depressive disorder
Treatment-resistant depression
Bipolar disorder
Medicine
Internal medicine
3
Papers
16
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of Excellence.
2021
Progress in Neuro-psychopharmacology & Biological Psychiatry
Orly Lipsitz
Roger S. McIntyre
Nelson B. Rodrigues
Tyler S. Kaster
Danielle S. Cha
Elisa Brietzke
Hartej Gill
Flora Nasri
Kangguang Lin
Mehala Subramaniapillai
Kevin Kratiuk
Kayla Teopiz
Leanna M. W. Lui
Yena Lee
Roger C.M. Ho
Margarita Shekotikhina
Rodrigo B. Mansur
Joshua D. Rosenblat
Show All
Source
Cite
Save
Citations (5)
Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series.
2021
American Journal of Geriatric Psychiatry
Orly Lipsitz
Joshua D. Di Vincenzo
Nelson B. Rodrigues
Danielle S. Cha
Yena Lee
David Greenberg
Kayla Teopiz
Roger C.M. Ho
Bing Cao
Kangguang Lin
Mehala Subramaniapillai
Alastair J. Flint
Kevin Kratiuk
Roger S. McIntyre
Joshua D. Rosenblat
Show All
Source
Cite
Save
Citations (7)
The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence.
2020
Journal of Psychopharmacology
Roger S. McIntyre
Nelson B. Rodrigues
Orly Lipsitz
Flora Nasri
Hartej Gill
Leanna Mw Lui
Mehala Subramaniapillai
Kevin Kratiuk
Kayla Teopiz
Roger C.M. Ho
Yena Lee
Rodrigo B. Mansur
Joshua D. Rosenblat
Show All
Source
Cite
Save
Citations (4)
1